Corona Remedies

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,542.00
14.45 (0.95%)
BSENSE

Feb 06

BSE+NSE Vol: 78.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

78.18 k (42.90%) Volume

Shareholding (Dec 2025)

FII

1.84%

Held by 18 FIIs

DII

0.05%

Held by 10 DIIs

Promoter

69.00%

Which are the latest news on Corona Remedies?

08-Feb-2026
No latest news for Corona Remedies found.

Why is Corona Remedies Ltd falling/rising?

08-Feb-2026

As of 08-Feb, the stock price of Corona Remedies Ltd is rising, currently at 1,542.00, reflecting a 0.95% increase. This rise is driven by strong performance metrics, positive technical indicators, and increased investor participation, including a new all-time high of Rs.1557.95.

As of 08-Feb, the stock price of Corona Remedies Ltd is rising, currently at 1,542.00, which reflects an increase of 14.45 (0.95%). This upward movement can be attributed to several factors. Firstly, the stock has shown strong performance over the past week, gaining 4.21%, significantly outperforming the Sensex, which only increased by 1.59%. Over the past month, the stock has risen by 7.81%, while the Sensex has declined by 1.74%. Year-to-date, Corona Remedies has increased by 11.27%, contrasting with a 1.92% drop in the Sensex.<BR><BR>Additionally, the stock reached a new 52-week and all-time high of Rs.1557.95 today, indicating strong investor confidence. The stock has been on a consecutive gain streak for the last two days, accumulating a total return of 4.4% in this period. It is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator.<BR><BR>Moreover, there has been a notable increase in investor participation, with a delivery volume of 36.06k on February 5, marking a 55.97% rise compared to the 5-day average delivery volume. This suggests heightened interest and confidence among investors. The stock's liquidity is also favorable, being liquid enough for a trade size of Rs 0.12 crore based on 2% of the 5-day average traded value.<BR><BR>Overall, the combination of strong performance metrics, positive technical indicators, and increased investor participation contributes to the rising stock price of Corona Remedies Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 9,425 Cr (Mid Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

24.61%

stock-summary
Price to Book

15.47

Revenue and Profits:
Net Sales:
342 Cr
(Quarterly Results - Dec 2025)
Net Profit:
41 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

03-Feb-2026 | Source : BSE

Audio Recording of conference call with Analyst / Investor on financial results for Q3 and Three Months and Nine Months ended December 31 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

03-Feb-2026 | Source : BSE

Newspaper Publication of Unaudited Financial Results for the third quarter and nine months ended December 31 2025

Announcement under Regulation 30 (LODR)-Investor Presentation

02-Feb-2026 | Source : BSE

Analyst/Investor Presentation

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.86
Tax Ratio
24.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.60%
ROCE (avg)
29.97%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
63
Industry P/E
32
Price to Book Value
15.57
EV to EBIT
46.47
EV to EBITDA
39.27
EV to Capital Employed
15.73
EV to Sales
7.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.85%
ROE (Latest)
24.61%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (6.38%)

FIIs

Held by 18 FIIs (1.84%)

Promoter with highest holding

Ankurbhai K Mehta (22.0%)

Highest Public shareholder

Sepia Investments Limited (19.76%)

Individual Investors Holdings

1.36%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "342.42",
          "val2": "361.13",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "83.16",
          "val2": "78.47",
          "chgp": "5.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.66",
          "val2": "1.93",
          "chgp": "-13.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "41.25",
          "val2": "52.15",
          "chgp": "-20.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.29%",
          "val2": "21.73%",
          "chgp": "2.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "707.67",
          "val2": "605.04",
          "chgp": "16.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "148.25",
          "val2": "116.34",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.92",
          "val2": "6.02",
          "chgp": "-34.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "98.55",
          "val2": "72.93",
          "chgp": "35.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.95%",
          "val2": "19.23%",
          "chgp": "1.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,050.09",
          "val2": "902.73",
          "chgp": "16.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "231.41",
          "val2": "185.76",
          "chgp": "24.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.58",
          "val2": "8.41",
          "chgp": "-33.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "139.80",
          "val2": "117.70",
          "chgp": "18.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.04%",
          "val2": "20.58%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,196.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239.98",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "149.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.06%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
342.42
361.13
-5.18%
Operating Profit (PBDIT) excl Other Income
83.16
78.47
5.98%
Interest
1.66
1.93
-13.99%
Exceptional Items
-19.10
0.00
Standalone Net Profit
41.25
52.15
-20.90%
Operating Profit Margin (Excl OI)
24.29%
21.73%
2.56%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
707.67
605.04
16.96%
Operating Profit (PBDIT) excl Other Income
148.25
116.34
27.43%
Interest
3.92
6.02
-34.88%
Exceptional Items
0.00
0.00
Standalone Net Profit
98.55
72.93
35.13%
Operating Profit Margin (Excl OI)
20.95%
19.23%
1.72%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,050.09
902.73
16.32%
Operating Profit (PBDIT) excl Other Income
231.41
185.76
24.57%
Interest
5.58
8.41
-33.65%
Exceptional Items
-19.10
0.00
Standalone Net Profit
139.80
117.70
18.78%
Operating Profit Margin (Excl OI)
22.04%
20.58%
1.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
1,196.42
NA
NA
Operating Profit (PBDIT) excl Other Income
239.98
NA
NA
Interest
10.60
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
149.05
NA
NA
Operating Profit Margin (Excl OI)
20.06%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Corona Remedies Ltd stock-summary
stock-summary
Corona Remedies Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available